Physiomics PLC provides consulting services to pharmaceutical companies, specializing in Modelling & Simulation and Biometrics. The company utilizes proprietary tools, including its Virtual Tumour™ platform, to support drug development by offering insights derived from complex data sets. Its business model primarily operates on a fee-for-service basis, with an emphasis on oncology but increasingly expanding into other therapeutic areas such as infectious diseases and dermatology. Physiomics serves clients globally, focusing on enhancing drug development processes through data-driven approaches and flexible service offerings.